Berkeley, CA, United States of America

David Tatum

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: David Tatum: Innovator in Metal Ion Ligands

Introduction

David Tatum, an accomplished inventor based in Berkeley, CA, has made significant contributions to the field of medicinal chemistry through his innovative patents. With a total of three patents under his name, Tatum's work focuses on the development of macrocyclic ligands that have potential applications in therapeutic and diagnostic settings.

Latest Patents

David Tatum’s recent patents include groundbreaking inventions centered around "Macrocyclic ligands with pendant chelating moieties and complexes thereof." These inventions relate to novel ligands and their complexes with metal ions, which are poised to offer valuable solutions in various applications, particularly in medical diagnostics and therapies. His continued research in this area showcases his commitment to advancing the field of chemistry.

Career Highlights

Throughout his career, Tatum has demonstrated a deep understanding of both theoretical and applied aspects of ligand chemistry. His work at Lumiphore, Inc. serves as a platform for his innovative ideas to come to fruition. His patent portfolio reflects a strong focus on developing ligands that can interact effectively with metal ions, providing enhanced functionality for various applications.

Collaborations

Working alongside talented colleagues such as Darren Magda and Jide Xu, Tatum has fostered a collaborative environment that promotes innovation and creativity. Their teamwork has proven fruitful, contributing to the development and success of their projects at Lumiphore, Inc. This collaborative spirit continues to drive their research initiatives forward.

Conclusion

David Tatum stands out as a prominent figure in the realm of ligand chemistry. His patents not only highlight his innovative approach to complex chemistry but also underscore the potential impact of his work on therapeutic and diagnostic technologies. As he continues to develop his ideas at Lumiphore, Inc., the scientific community looks forward to the future contributions he will undoubtedly make.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…